New study brings long-sought vaccines for deadly parasite closer to reality

December 13, 2012
This is an image of T. gondii. Credit: Sankar Ghosh

One major cause of illness from food-borne diseases is the parasite Toxoplasma gondii (T. gondii). New insights into how the immune system combats T. gondii are provided in a study published by Cell Press December 13th in the journal Immunity. The findings could lead to the development of long-sought vaccines to protect against T. gondii and related parasites.

To fight off pathogens, the immune system relies on Toll-like receptors (TLRs)—a class of proteins that recognize and activate immune responses. The important role of TLR11 in recognizing the T. gondii infection was previously demonstrated by a team led by Sankar Ghosh of Columbia University and Alan Sher of the National Institute of Allergy and . But scientists had not yet identified any TLRs—including TLR11—that could promote survival in infected animals.

In the new study, Ghosh, Sher, and their collaborators focused on the previously uncharacterized TLR12 because it is closely related to TLR11 and physically interacts with that receptor, suggesting that the two might work together to mount immune responses. When they genetically engineered mice to lack TLR12, they found that could not recognize or protect against T. gondii, and these mice quickly succumbed to infection. Although both TLR11 and TLR12 activate overlapping immune responses to T. gondii in certain types of cells, TLR12 also triggers responses in a distinct set of immune cells to promote survival.

This video is not supported by your browser at this time.
This shows Toxoplasma gondii tachyzoites egressing from an infected fibroblast and invading new cells. Credit: Dr. Gustavo Arrizabalaga

"Prior to this study, TLR12 had no known function in the immune system, and it was not known what pathogen this receptor recognized," Ghosh says. "We have demonstrated that TLR12 is essential for resistance to T. gondii in mice."

Because TLR12 also recognized another related parasite, the findings could have broad . "By investigating how immune cells expressing TLR12 organize the against T. gondii infection, we hope to identify new means of promoting protective immune responses against T. gondii and potentially other important parasite pathogens," Ghosh says.

Explore further: 'Promiscuous parasites' hijack host immune cells

More information: Koblansky et al.: "Recognition of profilin by toll-like receptor 12 is critical for host resistance to Toxoplasma gondii." DOI: 10.1016/j.immuni.2012.09.016

Related Stories

'Promiscuous parasites' hijack host immune cells

September 20, 2011

Toxoplasma gondii parasites can invade your bloodstream, break into your brain and prompt behavioral changes from recklessness to neuroticism. These highly contagious protozoa infect more than half the world's population, ...

Scientists create first mouse model of typhoid fever

October 25, 2012

Columbia University Medical Center (CUMC) researchers have created the first true mouse model of typhoid infection. The development promises to advance the study of typhoid and the creation of new vaccines against the infection, ...

Recommended for you

Epigenomic changes are key to innate immunological memory

August 31, 2015

A research team led by Keisuke Yoshida and Shunsuke Ishii of the RIKEN Molecular Genetics Laboratory has revealed that epigenomic changes induced by pathogen infections, mediated by a transcription factor called ATF7, are ...

Team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can "paralyze" CD4 T cells, immune components that help ...

SIV shrugs off antibodies in vaccinated monkeys

August 11, 2015

New research on monkeys vaccinated against HIV's relative SIV calls into question an idea that has driven AIDS vaccine work for years. The assumption: a protective vaccine only needs to stimulate moderate levels of antibodies ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.